Trifluoromethylaminoindane
Trifluoromethylaminoindane[edit]

Trifluoromethylaminoindane (TFMAI) is a chemical compound that belongs to the class of substituted amphetamines. It is a derivative of aminoindane and is characterized by the presence of a trifluoromethyl group attached to the aminoindane structure.
Chemical Properties[edit]
Trifluoromethylaminoindane is known for its unique chemical properties, which are influenced by the trifluoromethyl group. This group is known to enhance the lipophilicity of the compound, potentially affecting its pharmacokinetic properties. The presence of the trifluoromethyl group can also influence the compound's electron-withdrawing characteristics, which may impact its interaction with biological targets.
Synthesis[edit]
The synthesis of trifluoromethylaminoindane typically involves the introduction of the trifluoromethyl group into the aminoindane structure. This can be achieved through various chemical reactions, including nucleophilic substitution or electrophilic fluorination. The specific methods used can vary depending on the desired yield and purity of the final product.
Pharmacology[edit]
Trifluoromethylaminoindane is of interest in the field of pharmacology due to its potential effects on the central nervous system. As a derivative of aminoindane, it may interact with monoamine neurotransmitter systems, although specific studies on its pharmacological profile are limited. Research into its effects and potential therapeutic applications is ongoing.
Safety and Toxicology[edit]
The safety and toxicological profile of trifluoromethylaminoindane is not well-documented. As with many novel compounds, caution is advised in its handling and use. Potential risks may include neurotoxicity, cardiotoxicity, and other adverse effects associated with similar compounds.
Related Compounds[edit]
Trifluoromethylaminoindane is related to other aminoindane derivatives, such as 2-Aminoindane and 5,6-Methylenedioxy-2-aminoindane (MDAI). These compounds share a similar core structure but differ in their substituents, which can significantly alter their pharmacological properties.
Related Pages[edit]
References[edit]
-
Trifluoromethylaminoindane
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian